NANO Nuclear Energy Inc.(:NNE) 
NANO Nuclear Energy Inc. operates as a microreactor technology company. The company is developing ZEUS, a solid-core battery reactor, and ODIN, a low-pressure coolant reactor. It is also developing a high-assay low-enriched uranium fabrication facility to supply fuel to the nuclear reactor industry ...
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
- Early-Stage Nuclear Microreactor Developer: NANO Nuclear Energy Inc. is positioned as an early-stage company focused on developing portable, small-scale nuclear microreactor technologies, with progress dependent on technical milestones, partnerships, and regulatory pathways.
- Long Timelines and High Regulatory Complexity: Commercialization in nuclear typically involves multi-year development cycles, significant safety validation, and extensive licensing processes, which can delay revenue generation and increase execution risk.
- Funding Needs Likely Material Until Commercial Readiness: Given the R&D-intensive nature of advanced nuclear, the company may require continued external financing (equity, debt, grants, or strategic partners) to support development, testing, and licensing efforts.
- Strategic Partnerships and Government Programs Are Key Catalysts: Non-dilutive funding, government contracts, and partnerships with established nuclear, defense, or industrial players can meaningfully de-risk development and improve credibility with regulators and customers.
- Potential Upside Tied to Demand for Resilient, Off-Grid Power: If technical and licensing milestones are achieved, microreactors could address niche demand for reliable power in remote sites, critical infrastructure, and industrial applications, though market adoption remains uncertain.
Bull Thesis:
- Pioneering Micro-SMR Market & Niche Applications: NANO Nuclear Energy's strategic focus on micro-Small Modular Reactors (micro-SMRs) targets a potentially high-demand niche market. These compact, portable, and resilient energy solutions are ideal for remote power generation, military bases, data centers, disaster relief, and off-grid industrial applications, offering a first-mover advantage or specialized expertise in these segments.
- Alignment with Global Energy Security and Decarbonization Trends: Micro-SMRs offer a carbon-free, reliable, and resilient energy source, aligning perfectly with global initiatives for energy independence, grid stability, and climate change mitigation. This strong alignment could attract significant government support, funding, and strategic partnerships as nations seek to diversify their energy portfolios away from fossil fuels and enhance energy resilience.
- High Barriers to Entry & Potential for Strong IP: The nuclear energy sector, especially advanced reactor development, is characterized by extremely high barriers to entry due to stringent regulatory requirements, immense capital needs, and complex technological expertise. If NANO Nuclear Energy successfully develops proprietary technology and navigates the initial hurdles, it could establish a significant competitive moat and strong intellectual property, protecting its market position.
- Potential for Significant Government and Strategic Investment: Given the strategic importance of advanced nuclear technology for national security, energy independence, and climate goals, NANO Nuclear Energy could become a recipient of substantial government grants, subsidies, and strategic investments. This external funding could significantly de-risk their development pathway, accelerate commercialization, and provide a competitive edge.
Bear Thesis:
- Early Stage, High Capital Requirements, and Dilution Risk: NANO Nuclear Energy is an early-stage company in an extremely capital-intensive industry. Developing, testing, and licensing nuclear reactors requires billions of dollars over many years. The company will likely need to raise substantial capital repeatedly, leading to significant shareholder dilution and potential challenges in securing sufficient funding to reach commercialization.
- Protracted Development and Regulatory Timelines: The development and commercialization of new nuclear reactor technology are notoriously long processes, often spanning decades. Regulatory approval from bodies like the NRC is rigorous, complex, and time-consuming. This extended timeline means that significant revenue and profitability are many years away, posing a long-term risk for investors and requiring sustained capital.
- Intense Competition from Established and Well-Funded Players: NANO Nuclear Energy faces formidable competition from larger, more established companies with deeper pockets and more advanced SMR projects (e.g., NuScale Power, GE-Hitachi, Rolls-Royce). These competitors have significant resources for R&D, lobbying, and navigating regulatory landscapes, making it challenging for a smaller player to gain market share and secure contracts.
- Technological and Commercial Viability Risks: While promising, micro-SMR technology is still largely unproven at a commercial scale. There are inherent technological risks in developing and deploying these advanced reactors, including safety, operational efficiency, and waste management. Furthermore, the economic viability and competitiveness against other energy sources (including larger SMRs and renewables with storage) remain uncertain, potentially limiting market adoption.
Main Competitors:
- NuScale Power Corporation ($SMR) (VOYGR SMR power plants), NuScale is a leader in the SMR market, having the first SMR design certified by the U.S. Nuclear Regulatory Commission (NRC). They compete with NANO for market share in advanced nuclear energy solutions, particularly for larger-scale SMR deployments, and for government funding and industry partnerships. Their advanced stage of commercialization and regulatory approval presents a significant competitive advantage.
- Oklo Inc. ($OKLO) (Aurora microreactor), Oklo is a direct competitor in the microreactor segment, focusing on small, modular, and passively safe designs for applications like remote communities, industrial sites, and data centers. They are actively pursuing regulatory approval and commercialization, directly vying for the same niche market and early adopter customers as NANO Nuclear Energy.
- TerraPower LLC (Natrium Reactor (sodium-cooled fast reactor)), Backed by Bill Gates, TerraPower is a major player in advanced nuclear reactor development, including SMRs, with innovative designs like the Natrium reactor which incorporates molten salt energy storage. While not solely focused on microreactors, they compete for talent, government funding, and future market share in the broader advanced nuclear sector, pushing the boundaries of nuclear technology.
- Westinghouse Electric Company LLC (eVinci microreactor, AP300 SMR), Westinghouse is a long-established global leader in nuclear technology and is actively developing both SMRs (AP300) and microreactors (eVinci). Their extensive experience, established supply chain, and global presence make them a formidable competitor, particularly in the microreactor space where their eVinci design directly targets similar applications as NANO's offerings.
Moat:
NANO Nuclear Energy operates in the highly capital-intensive, regulated, and technologically complex advanced nuclear energy sector, specifically targeting the emerging microreactor and SMR markets. Their potential moat will depend on the speed of their technological development, regulatory approval, cost-effectiveness, and ability to secure early deployment contracts. Competition comes from established nuclear giants with deep pockets and decades of experience (e.g., Westinghouse), well-funded startups with significant regulatory headway (e.g., NuScale, Oklo), and innovative players backed by influential figures (e.g., TerraPower). The market is still nascent, and success will hinge on demonstrating safety, reliability, and economic viability faster than competitors, while navigating complex regulatory landscapes and securing substantial funding.
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
operating expenses | ||||||||
general and administrative | 6,886,603 | 6,046,512 | 5,324,260 | 15,697,178 | 2,494,570 | 2,297,481 | 2,301,307 | 1,423,309 |
research and development | 5,400,410 | 4,162,534 | 3,666,513 | 6,712,543 | 904,923 | 895,198 | 2,019,812 | 290,539 |
change in fair value of contingent consideration | -727,500 | 203,500 | 401,500 | 78,250 | 524,250 | -451,500 | 385,500 | |
income from operations | 11,559,513 | -82,020,520 | 9,392,273 | 22,487,971 | 3,923,743 | -18,279,937 | 4,706,619 | 1,713,848 |
yoy | 194.60% | 348.69% | 99.55% | 1212.13% | ||||
qoq | -114.09% | -973.28% | -58.23% | 473.13% | -121.46% | -488.39% | 174.62% | |
other income | 5,013,557 | 2,362,136 | 1,797,690 | 1,179,250 | 810,381 | 249,443 | 38,372 | 36,220 |
unrealized loss on marketable securities | -122,838 | |||||||
gain on settlement of accounts receivable | 152,515 | |||||||
net income | -6,516,279 | -8,050,410 | -7,594,583 | -21,308,721 | -3,113,362 | -2,491,736 | -4,668,247 | -1,677,628 |
yoy | 109.30% | 223.08% | 62.69% | 1170.17% | ||||
qoq | -19.06% | 6.00% | -64.36% | 584.43% | 24.95% | -46.62% | 178.26% | |
other comprehensive loss: | ||||||||
cumulative translation adjustment | -10,720 | |||||||
comprehensive loss | -6,526,999 | |||||||
net income per share | ||||||||
basic | -0.13 | -0.19 | -0.19 | -0.57 | -0.09 | -0.08 | -0.17 | -0.07 |
diluted | -0.13 | -0.19 | -0.19 | -0.57 | -0.09 | -0.08 | -0.17 | -0.07 |
weighted-average shares of common stock outstanding: | ||||||||
basic | 49,807,203 | 37,910,547 | 38,985,143 | 37,074,514 | 33,964,495 | 26,222,442 | 27,730,227 | 23,861,244 |
diluted | 49,807,203 | 37,910,547 | 38,985,143 | 37,074,514 | 33,964,495 | 26,222,442 | 27,730,227 | 23,861,244 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
assets | ||||||||
current assets: | ||||||||
cash and cash equivalents | 577,533,949 | 203,265,052 | 210,182,375 | 118,550,451 | 123,267,673 | 28,507,257 | 13,789,532 | |
accounts receivable | 86,381 | 250,000 | 250,000 | |||||
prepaid expenses | 1,014,889 | 902,861 | 1,420,084 | 672,222 | 1,623,694 | 833,947 | 530,188 | 634,977 |
deposits, current | 1,850,000 | 250,000 | 350,000 | 250,000 | 3,560,000 | |||
marketable securities, at fair value | 279,677 | |||||||
total current assets | 580,764,896 | 204,667,913 | 212,202,459 | 119,472,673 | 128,451,367 | 29,341,204 | 14,319,720 | 6,590,005 |
deferred offering costs | 435,500 | 300,000 | 130,000 | |||||
deposits, non-current | 274,001 | 269,235 | 269,235 | 269,235 | 235,235 | |||
property, plant and equipment | 11,029,284 | 9,783,777 | 5,343,228 | 5,275,936 | 1,669,631 | 1,689,607 | ||
right-of-use assets | 2,477,435 | 2,560,896 | 2,642,245 | 2,722,859 | ||||
long-term investments, related party | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | ||
in-process research and development | 9,075,045 | 9,075,045 | 9,075,045 | 9,075,045 | ||||
total assets | 606,056,161 | 228,656,866 | 231,532,212 | 138,815,748 | 134,142,439 | 35,096,170 | 16,427,718 | 8,870,018 |
liabilities and stockholders’ equity | ||||||||
current liabilities: | ||||||||
accounts payable and accrued liabilities | 2,540,706 | 1,314,596 | 597,453 | 2,535,498 | 899,253 | 761,479 | 231,611 | 299,508 |
lease liabilities, current | 540,801 | 534,128 | 493,169 | 454,295 | ||||
contingent consideration | 1,250,500 | 1,978,000 | 1,774,500 | 1,373,000 | 1,294,750 | 770,500 | 1,222,000 | |
total current liabilities | 4,332,007 | 3,826,724 | 2,906,789 | 4,392,793 | 2,516,873 | 1,838,331 | 1,805,892 | 605,459 |
lease liabilities, non-current | 2,145,365 | 2,261,414 | 2,314,645 | 2,396,465 | ||||
total liabilities | 6,477,372 | 6,088,138 | 5,221,434 | 6,789,258 | 4,085,403 | 3,488,714 | 3,424,402 | 2,234,050 |
stockholders’ equity | ||||||||
preferred stock, 0.0001 par value... | ||||||||
common stock, 0.0001 par value... | 5,056 | 4,173 | 4,154 | 3,727 | 3,675 | 3,072 | 2,900 | 2,601 |
additional paid-in capital | 663,601,589 | 280,065,412 | 275,757,071 | 173,878,627 | 150,600,504 | 49,038,165 | 27,942,461 | 16,907,165 |
accumulated deficit | -64,017,136 | -57,500,857 | -49,450,447 | -41,855,864 | -20,547,143 | -17,433,781 | -14,942,045 | -10,273,798 |
accumulated other comprehensive loss | -10,720 | |||||||
total stockholders’ equity | 599,578,789 | 222,568,728 | 226,310,778 | 132,026,490 | 130,057,036 | 31,607,456 | 13,003,316 | 6,635,968 |
total liabilities and stockholders’ equity | 606,056,161 | 228,656,866 | 231,532,212 | 138,815,748 | 134,142,439 | |||
due to related parties | 41,667 | 30,000 | 25,000 | 25,000 | ||||
right-of-use asset | 1,786,206 | |||||||
liabilities, mezzanine, and stockholders’ equity | ||||||||
lease liability, current | 322,870 | 281,352 | 352,281 | 280,951 | ||||
lease liability, non-current | 1,568,530 | 1,650,383 | 1,618,510 | 1,628,591 | ||||
deposits | 235,235 | 235,235 | 235,235 | |||||
right of use asset | 1,830,124 | 1,872,763 | 1,914,778 | |||||
mezzanine equity | ||||||||
common stock subject to possible redemption; nil and 2,000,000 shares as of september 30, 2024 and september 30, 2023, respectively | ||||||||
total liabilities, mezzanine equity, and stockholders’ equity | 35,096,170 | 16,427,718 | 8,870,018 | |||||
common stock subject to possible redemption; 0 shares as of june 30, 2024 and 2,000,000 shares as of september 30, 2023 | ||||||||
cash | 5,955,028 | |||||||
common stock subject to possible redemption; 0 shares as of march 31, 2024 and 2,000,000 shares as of september 30, 2023 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|
operating activities | |||||||
net loss | -6,516,279 | -8,050,410 | -7,594,583 | -21,308,721 | -3,113,362 | ||
adjustments to reconcile net loss to net cash from operating activities: | |||||||
amortization of right-of-use assets | 83,462 | 81,348 | 80,614 | ||||
depreciation | 208,408 | 207,309 | 108,336 | 19,541 | 19,976 | ||
equity-based compensation | 2,072,690 | 1,369,373 | 978,789 | 167,800 | 0 | ||
bank revaluation | 731 | ||||||
change in fair value of contingent consideration | -727,500 | ||||||
unrealized gain on marketable securities | 122,838 | ||||||
gain on settlement on accounts receivable | -152,515 | ||||||
change in assets and liabilities: | |||||||
accounts receivable | -86,381 | 0 | |||||
prepaid expenses | -112,028 | 517,223 | -747,862 | 951,472 | -789,747 | -303,759 | 104,789 |
accounts payable and accrued liabilities | 1,226,110 | 717,142 | -1,938,045 | 1,636,244 | 137,774 | 529,868 | -67,897 |
due to related parties | -41,667 | 11,667 | 30,000 | -25,000 | 25,000 | -25,000 | |
lease liabilities | -109,376 | -12,272 | -42,946 | ||||
net cash from operating activities | -3,989,840 | -4,908,454 | -9,092,530 | -2,378,453 | -3,242,526 | -2,510,351 | -2,544,591 |
capital expenditures | 0 | -4,647,858 | -175,628 | 0 | 0 | 0 | 0 |
free cash flows | -3,989,840 | -9,556,312 | -9,268,158 | -2,378,453 | -3,242,526 | -2,510,351 | -2,544,591 |
investing activities | |||||||
deposits | -1,604,766 | 100,000 | -100,000 | 0 | 0 | ||
construction-in-progress | -1,453,915 | ||||||
net cash from investing activities | -3,058,681 | -4,647,858 | -175,628 | -9,140,891 | -3,560,000 | ||
financing activities | |||||||
proceeds from common stock issuances | 400,000,033 | 0 | 105,000,003 | 0 | 101,400,012 | 20,700,000 | 11,787,500 |
offering costs | -21,520,711 | 0 | -6,017,700 | 0 | -9,058,856 | -2,146,424 | |
proceeds from exercise of warrants | 2,445,048 | 2,818,989 | 1,269,779 | 6,373,122 | 8,014,286 | ||
proceeds from exercise of stock options | 540,000 | 120,000 | 648,000 | 429,000 | 1,207,500 | ||
payment of deferred offering costs | -135,500 | 0 | |||||
net cash from financing activities | 381,328,870 | 2,638,989 | 100,900,082 | 6,802,122 | 101,562,942 | -16,490,532 | 10,379,095 |
net increase in cash and cash equivalents | 374,280,349 | 91,631,924 | |||||
cash and cash equivalents, beginning of period | 203,265,052 | 0 | 0 | 28,507,257 | |||
effect of exchange rate changes on cash | -11,452 | ||||||
cash and cash equivalents, end of period | 577,533,949 | 91,631,924 | -4,717,222 | 123,267,673 | |||
adjustments to reconcile net loss to net cash used in operating activities: | |||||||
r&d acquisition paid-in equity | |||||||
changes in fair value of contingent liability | 203,500 | 401,500 | |||||
contingent liability | 524,250 | -451,500 | |||||
in-process research and development | 0 | 0 | |||||
increase in long-term investments | |||||||
additions to property, plant and equipment | -4,647,858 | -175,628 | |||||
net increase in cash | 94,760,416 | 14,717,725 | 7,834,504 | ||||
cash and cash equivalents, beginning of year | |||||||
cash and cash equivalents, end of year | |||||||
non-cash supplemental disclosures | |||||||
inception of right-of-use asset / lease liability | 0 | ||||||
r&d acquisition paid in equity | 0 | ||||||
proceeds from stock subscriptions | |||||||
non-cash transactions: | |||||||
conversion from mezzanine equity to stockholders’ equity | 0 | ||||||
inception of right-of-use asset / liability | |||||||
amortization of right-of-use asset | 43,918 | ||||||
lease liability | -40,335 | -39,056 | 61,249 | ||||
deposits, current | -3,560,000 | ||||||
amortization of right of use asset | 42,639 | 42,015 | |||||
right of use assets acquired in exchange for new operating lease liabilities | |||||||
net income | -4,668,247 | ||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||
inception of right of use asset / liability | 0 | ||||||
4 | |||||||
cash, beginning of period | |||||||
cash, end of period |